That reference is out of date. They referred to an 8 year old European summary paper which itself used data which was 10 years old.
Here is the latest 600 subject clinical study conducted on their largest customer base. The results are definitive and beyond dispute. The A2 marketing machine is working on their communications strategy at which point it will be major news:
https://www.ncbi.nlm.nih.gov/m/pubmed/29070042/
What is your vision for a2m?, page-48
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.75 |
Change
0.110(1.66%) |
Mkt cap ! $4.865B | |||
| Open | High | Low | Value | Volume |
| $6.63 | $6.75 | $6.63 | $5.284M | 788.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 3432 | $6.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.75 | 61807 | 18 |
View Market Depth
| Last trade - 15.18pm 28/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |